MLTX - GAAP EPS of -$0.27 beats by $0.07 November, 14 2022 09:27 AM MoonLake Immunotherapeutics press release ( NASDAQ: MLTX ): Q3 GAAP EPS of -$0.27 beats by $0.07 . As of September 30, 2022, MoonLake held cash, cash equivalents of $83.5 million, For further details see: GAAP EPS of -$0.27 beats by $0.07